The Realization Of Sido Muncul CSR Funds Reaches IDR 5.83 Billion Until November 2023

Director of Sido Muncul Irwan Hidayat. (Photo: Doc. Sido Muncul)

JAKARTA - PT Industri Jamu dan Pharmacy Sido Muncul Tbk (SIDO) participated in the PPublic Expose Live 2023 event organized by the Indonesia Stock Exchange, Wednesday 29 November. One of the materials presented by the producer of Tolak Angin and Kuku Bima Energy-G is regarding the use of Corporate Social Responsibility (CSR) funds.

"As a form of the Company's responsibility to the community, the Company distributes assistance in the form of health assistance such as Free Cataract Operations, Sumbing and Langit-Gangit Lip Surgery, assistance for stunting children and cash assistance for duafa and orphans, as well as Islamic Boarding Schools in several areas," explained Sido Muncul's management in the presentation material that was circulated to the media.

He explained that the total realization of Sido Muncul's CSR funds until November 2023 was IDR 5,835,820,466. The free lipbing operation carried out by Sido Muncul was last carried out at Hermina Hospital Bogor on Friday, October 6, in collaboration with Smile Train Indonesia.

Director of Sido Muncul, Irwan Hidayat, said that the lip surgery was given to 50 patients covering the Bogor area, West Java. The funds disbursed by Sido Muncul reached Rp. 325 million for this activity.

"Cleft lip operation of 50 patients at Hermina Hospital. Since 2018 we have had lip surgery with 452 and 50 who are now together with Hermina," said Irwan at the time.

Furthermore, said Irwan, since the last few years his party has focused on helping the Indonesian people to treat a number of diseases. Starting from cataract surgery, cleft lip, to assistance to stunting sufferers.

He admitted that he understood the feelings of parents who knew their child was born with imperfect lips. For this reason, Sido Muncul wants to help ease the burden.

"Since last year we have started to seriously enter after the cataracts, the important lip of the cleft lip, especially since the cleft lip is not financed by BPJS. So, hopefully, what we are assisting Sido Muncul can be useful," explained Irwan.

Regarding its performance in the third quarter of this year, the Company managed to reap sales of IDR 2.36 trillion and a net profit of IDR 586.57 billion. Meanwhile, SIDO's capital expenditure for nine months in 2023 is IDR 47 billion.

"The company will continue to improve performance in a better direction to meet investor and stakeholder expectations. Consistently implementing Good Corporate Governance by complying with related regulations. Implement information disclosure as regulated by the Financial Services Authority and the Indonesia Stock Exchange," explained SIDO management.